Clinical Trial Update: Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating high-dose, targeted radiation added to standard therapy for locally advanced, inoperable non-small cell lung cancer. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 | Phase 3 | Status: RECRUITING